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Glucagon-like peptide-1 (GLP-1), a metabolic signal molecule, regulates reproduction,
although, the involved molecular mechanisms have not been elucidated, yet. Therefore,
responsiveness of gonadotropin-releasing hormone (GnRH) neurons to the GLP-1
analog Exendin-4 and elucidation of molecular pathways acting downstream to the
GLP-1 receptor (GLP-1R) have been challenged. Loose patch-clamp recordings
revealed that Exendin-4 (100 nM–5 µM) elevated firing rate in hypothalamic GnRH-
GFP neurons of male mice via activation of GLP-1R. Whole-cell patch-clamp
measurements demonstrated increased excitatory GABAergic miniature postsynaptic
currents (mPSCs) frequency after Exendin-4 administration, which was eliminated
by the GLP-1R antagonist Exendin-3(9–39) (1 µM). Intracellular application of the
G-protein inhibitor GDP-β-S (2 mM) impeded action of Exendin-4 on mPSCs,
suggesting direct excitatory action of GLP-1 on GnRH neurons. Blockade of nitric-
oxide (NO) synthesis by Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME;
100 µM) or N5-[Imino(propylamino)methyl]-L-ornithine hydrochloride (NPLA; 1 µM) or
intracellular scavenging of NO by 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-
1-oxyl-3-oxide (CPTIO; 1 mM) partially attenuated the excitatory effect of Exendin-4.
Similar partial inhibition was achieved by hindering endocannabinoid pathway
using cannabinoid receptor type-1 (CB1) inverse-agonist 1-(2,4-dichlorophenyl)-
5-(4-iodophenyl)-4-methyl-N-(1-piperidyl) pyrazole-3-carboxamide (AM251; 1 µM).
Simultaneous blockade of NO and endocannabinoid signaling mechanisms eliminated
action of Exendin-4 suggesting involvement of both retrograde machineries. Intracellular
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application of the transient receptor potential vanilloid 1 (TRPV1)-antagonist 2E-
N-(2, 3-Dihydro-1,4-benzodioxin-6-yl)-3-[4-(1, 1-dimethylethyl)phenyl]-2-Propenamide
(AMG9810; 10 µM) or the fatty acid amide hydrolase (FAAH)-inhibitor PF3845 (5 µM)
impeded the GLP-1-triggered endocannabinoid pathway indicating an anandamide-
TRPV1-sensitive control of 2-arachidonoylglycerol (2-AG) production. Furthermore,
GLP-1 immunoreactive (IR) axons innervated GnRH neurons in the hypothalamus
suggesting that GLP-1 of both peripheral and neuronal sources can modulate GnRH
neurons. RT-qPCR study confirmed the expression of GLP-1R and neuronal NO
synthase (nNOS) mRNAs in GnRH-GFP neurons. Immuno-electron microscopic analysis
revealed the presence of nNOS protein in GnRH neurons. These results indicate that
GLP-1 exerts direct facilitatory actions via GLP-1R on GnRH neurons and modulates
NO and 2-AG retrograde signaling mechanisms that control the presynaptic excitatory
GABAergic inputs to GnRH neurons.
Keywords: GnRH neuron, GABA, glucagon-like peptide-1, endocannabinoid, nitric oxide, retrograde signaling,
TRPV1, anandamide
INTRODUCTION
Glucagon-like peptide-1 (GLP-1) is one of the metabolic signal
molecules, discovered in humans in 1987 (Kreymann et al.,
1987). It is secreted by the intestinal L-cells as a gut hormone
(Mojsov et al., 1990; Baggio and Drucker, 2007). It reduces
food intake (Kinzig et al., 2002; Hayes et al., 2008), inhibits
gastric emptying (Chelikani et al., 2005), and increases glucose-
stimulated insulin secretion (Komatsu et al., 1989; Drucker, 1998;
Knauf et al., 2005). Radiolabeled GLP-1 and GLP-1 receptor
(GLP-1R) agonists can cross the blood-brain barrier (Hunter
and Hölscher, 2012), suggesting an ability to reach various
control centers of homeostasis. In addition to the small intestine,
GLP-1 is also produced in neurons of the lower brain stem,
clustering in the nucleus of the solitary tract (NST) and the
reticular nucleus of the medulla oblongata (Larsen et al., 1997;
Merchenthaler et al., 1999; Vrang and Larsen, 2010). GLP-1
immunoreactive (IR) fibers and terminals were observed in the
hypothalamus, thalamus, septal regions, cortex and hindbrain
as reviewed in Trapp and Cork (2015). GLP-1R is widely
expressed in the human and rodent brains such as in neurons
of the circumventricular organs, amygdala, hypothalamic nuclei,
ventrolateral medulla, NST, thalamic paraventricular nucleus,
hippocampus and cortex, in various loci for hypothalamic
regulation of glucose homeostasis, and parabrachial nucleus a
regulatory center of feeding behavior (Goke et al., 1995; Wei and
Mojsov, 1995; Scrocchi et al., 1996; Li et al., 2003; Sandoval et al.,
2008; Richard et al., 2014; Richards et al., 2014; Cork et al., 2015;
Sandoval and Sisley, 2015).
In addition to regulating energy homeostasis, GLP-1
is a potent regulator of reproduction. Accordingly, its
intracerebroventricular injection resulted in an increase in the
plasma luteinizing hormone (LH) level of male rats, and GLP-1
elicited a concentration-dependent increase in gonadotropin-
releasing hormone (GnRH) release from the immortalized
GnRH-producing GT1–7 neurons (Beak et al., 1998). Male
GLP-1R knockout mice exhibited reduced gonadal weights,
and females possessed a slight delay in the onset of puberty
(MacLusky et al., 2000). GLP-1 doubled the amplitude of the
preovulatory LH surge, influenced estradiol and progesterone
levels and increased the number of Graafian follicles and
corpora lutea (Outeiriño-Iglesias et al., 2015). Since GnRH
neurons orchestrate the hypothalamo-pituitary-gonadal axis,
any GLP-1-induced modulation of the GnRH neuronal system
itself has a major impact on various events of reproductive
physiology. Although some of the intracellular elements of
the GLP-1 activated pathway such as an elevated cytoplasmic
cAMP level has already been identified in the GT1–7 cells
(Beak et al., 1998), the exact target and detailed molecular
mechanism involved in the downstream actions of GLP-1 in
GnRH neurons of the rodent preoptic area have not been
elucidated, yet.
Therefore, the present study was aimed at revealing the
putative direct effects of GLP-1 upon electric activity of GnRH
neurons in male mice. Patch-clamp recordings in GnRH-GFP
neurons revealed GLP-1 induced changes in firing. Then,
effects of GLP-1 in the GABAergic miniature postsynaptic
currents (mPSCs) were examined, because GABA is the main
excitatory neurotransmitter via GABAA-R in GnRH neurons
(Moenter and DeFazio, 2005; Yin et al., 2008; Herbison and
Moenter, 2011). GABAergic mPSCs in GnRH neurons are
dampened by the tonic and triggered retrograde release of
endocannabinoid 2-arachidonoylglycerol (2-AG; Farkas et al.,
2010, 2013). In contrast, nitric oxide (NO) can facilitate
postsynaptic currents in hypothalamic neurons (Di et al., 2009).
Thus, in the GLP-1R-mediated actions the regulatory role
of retrograde endocannabinoid and putative NO signaling
pathways was addressed by tools of slice electrophysiology
in GnRH neurons of mice. Immunocytochemical study
was carried out to reveal whether axons containing GLP-1
innervate GnRH neurons. Immuno-electron microscopic
analysis addressed the putative expression of neuronal NO
synthase (nNOS) enzyme in GnRH neurons. Meanwhile,
RT-qPCR analysis of individual GnRH neurons was used to
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Adult male mice were used from local colonies bred at the
Medical Gene Technology Unit of the Institute of Experimental
Medicine (IEM). They were housed in light (12:12 light-dark
cycle, lights on at 06:00 h)—and temperature (22 ± 2◦C)
controlled environment, with free access to standard food and tap
water. GnRH-green fluorescent protein (GnRH-GFP) transgenic
mice (n = 70) bred on a C57Bl/6J genetic background were
used for electrophysiological experiments. In this animal model,
a GnRH promoter segment drives selective GFP expression in
the majority of GnRH neurons (Suter et al., 2000). Experiments
studying the presence of nNOS in GnRH neurons were carried
out using C57Bl/6J mice and mice lacking nNOS (nNOS−/−)
generated by the Jackson Laboratory (Bar Harbor, ME, USA;
Szabadits et al., 2007).
Ethics Statement
All animal studies were carried out with permissions from
the Animal Welfare Committee of the IEM Hungarian
Academy of Sciences (Permission Number: A5769-01) and
in accordance with legal requirements of the European
Community (Decree86/609/EEC). All animal experimentation
described was conducted in accord with accepted standards of
humane animal care and all efforts were made to minimize
suffering. Sacrifice of animals for electrophysiological studies was
carried out by decapitation in deep anesthesia by Isoflurane
inhalation.
Brain Slice Preparation and Recordings
Mice were deeply anesthetized using Isoflurane inhalation. The
brain was removed rapidly and immersed in ice cold sodium-
free artificial cerebrospinal fluid (Na-free aCSF) bubbled with
a mixture of 95% O2 and 5% CO2. The solution contained
the following (in mM): saccharose 205, KCl 2.5, NaHCO3 26,
MgCl2 5, NaH2PO4 1.25, CaCl2 1, glucose 10. Hypothalamic
blocks were dissected and 250 µm thick coronal slices were
prepared from the medial septum/preoptic area with a Leica
VT-1000S vibratome (Leica Microsystems, Wetzlar, Germany)
in the ice-cold oxygenated Na-free aCSF. The slices were
equilibrated in normal aCSF (in mM): NaCl 130, KCl 3.5,
NaHCO3 26, MgSO4 1.2, NaH2PO4 1.25, CaCl2 2.5, glucose
10, saturated with O2/CO2 for 1 h. Initial temperature of aCSF
was 33◦C which was left to cool to room temperature during
equilibration.
Recordings were carried out in oxygenated aCSF at
33◦C. Axopatch-200B patch-clamp amplifier, Digidata-
1322A data acquisition system, and pCLAMP 10.4 software
(Molecular Devices Co., Silicon Valley, CA, USA) were used
for recording. Cells were visualized with a BX51WI IR-
DIC microscope (Olympus Co., Tokyo, Japan). The patch
electrodes (OD = 1.5 mm, thin wall, Hilgenberg GmBH,
Malsfeld, Germany) were pulled with a Flaming-Brown P-
97 puller (Sutter Instrument Co., Novato, CA, USA) and
polished with an MF-830 microforge (Narishige Inc., Tokyo,
Japan).
GnRH-GFP neurons in the close proximity of the vascular
organ of lamina terminalis (OVLT; Bregma 0.49–0.85 mm) were
identified by brief illumination at 470 nm using an epifluorescent
filter set, based on their green fluorescence, typical fusiform
shape and characteristic topography (Suter et al., 2000).
Loose-patch or whole-cell patch-clamp measurements were
carried out with an initial control recording (5 min), then
Exendin-4 (100 nM–5 µM) or the NO-donor L-arginine
(1 mM) was added to the aCSF in a single bolus onto the
slice in the recording chamber and the recording continued
for a subsequent 10 min. The GLP-1R antagonist Exendin-
3(9–39) (1 µM), the NO-synthase (NOS) inhibitor Nω-Nitro-
L-arginine methyl ester hydrochloride (L-NAME; 100 µM), the
nNOS inhibitor N5-[Imino(propylamino)methyl]-L-ornithine
hydrochloride (NPLA; 1 µM) or the cannabinoid receptor
type-1 (CB1) inverse agonist AM251 (1 µM) were added
to the aCSF 10 min before adding the Exendin-4 and they
were then continuously present in the aCSF during the
electrophysiological recording. Intracellularly applied drugs,
such as the membrane impermeable G-protein inhibitor
Guanosine 5′-[β;-thio] diphosphate (GDP-β-S; 2 mM), the
membrane impermeable NO-scavenger 2-(4-carboxyphenyl)-
4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (CPTIO; 1 mM),
the transient receptor potential vanilloid 1 (TRPV1) antagonist
AMG9810 (10 µM), NPLA (1 µM), or the anandamide-
degrading enzyme fatty acid amide hydrolase (FAAH) inhibitor
PF3845 (5 µM) were added to the intracellular pipette solution
and after achieving whole-cell patch clamp configuration, we
waited 15 min to reach equilibrium in the intracellular milieu
before starting recording. Each neuron served as its own control
when drug effects were evaluated.
Reagents and Chemicals
Exendin-4 (100 nM–5 µM, Tocris, Bristol, UK, Eng et al.,
1992; Raufman et al., 1992; Acuna-Goycolea and van den
Pol, 2004); NO-donor L-arginine (1 mM, Sigma, St. Louis,
MO, USA, Makara et al., 2007; Lameu et al., 2012); GLP-1R
antagonist Exendin-3(9–39) (1 µM, Tocris, Eng et al., 1992;
Raufman et al., 1992; Acuna-Goycolea and van den Pol, 2004);
NOS inhibitor L-NAME (100 µM; Sigma, Makara et al.,
2007; Poglia et al., 2011); nNOS inhibitor NPLA (1 µM;
Tocris, Chow et al., 2012; Filpa et al., 2015; Gong et al., 2015);
CB1 inverse agonist 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-
methyl-N-(1-piperidyl) pyrazole-3-carboxamide(AM251; 1 µM;
Tocris, Farkas et al., 2010, 2013); G-protein inhibitor GDP-
β-S (2 mM; Sigma, Meis et al., 2002; Ponzio and Hatton,
2005; McDermott and Schrader, 2011); NO-scavenger CPTIO
(1 mM, Sigma, Makara et al., 2007; Mironov and Langohr,
2007);TRPV1antagonist2E-N-(2,3-Dihydro-1,4-benzodioxin-6-
yl)-3-[4-(1,1-dimethylethyl)phenyl]-2-Propenamide (AMG9810;
10 µM; Sigma, Vriens et al., 2011; Liu and Zhuo, 2014; Jian
et al., 2016); anandamide-degrading enzyme FAAH inhibitor
PF3845 (N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]
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oxy]phenyl]methyl]-1-piperidinecarboxamide hydrate; 5 µM;
Sigma, Lee et al., 2015).
Loose-Patch-Clamp Experiments
Loose-patch measurements were carried out to record action
currents in GnRH-GFP neurons of the acute brain slice as
described earlier (Farkas et al., 2010). Briefly, pipette potential
was set to 0 mV, pipette resistance was 1–2 MΩ, resistance
of loose-patch seal 7–40 MΩ. The pipette solution contained
(in mM): NaCl 150, KCl 3.5, CaCl2 2.5, MgCl2 1.3, HEPES 10,
glucose 10 (pH= 7.3 with NaOH).
Whole-Cell Patch-Clamp Experiments
Resting potential (Vrest) was recorded in current-clamp. The
mPSCs in GnRH neurons were measured as described earlier
(Farkas et al., 2010). Briefly, the neurons were voltage-clamped
at –70 mV holding potential. Intracellular pipette solution
contained (in mM): HEPES 10, KCl 140, EGTA 5, CaCl2 0.1, Mg-
ATP 4, Na-GTP 0.4 (pH= 7.3 with NaOH). The resistance of the
patch electrodes was 2–3 MΩ. Spike-mediated transmitter release
was blocked in all experiments by adding the voltage-sensitive
Na-channel inhibitor tetrodotoxin (TTX, 660 nM, Tocris) to
the aCSF 10 min before mPSCs or Vrest were recorded. The
mPSCs recorded under the conditions used in our experiments
were related to GABAA-R activation (Sullivan et al., 2003;
Farkas et al., 2010). This GABAergic input via GABAA-R is
excitatory to GnRH cells (Moenter and DeFazio, 2005; Yin
et al., 2008; Herbison and Moenter, 2011), although we have to
note that GABA inhibits GnRH neurons via GABAB-receptors
(GABAB-R; Herbison and Moenter, 2011; Liu and Herbison,
2011).
GLP-1 and GnRH Double
Immunofluorescent Studies in the Mouse
Hypothalamus
Adult male mice were deeply anesthetized and perfused
transcardially with 4% paraformaldehyde (in 0.05 M PBS,
pH = 7.4). Brains were removed from the skulls, postfixed
for 30 min, and then equilibrated in 20% sucrose-Phosphate-
buffered saline (PBS) for cryoprotection. Twenty-five µm thick
serial coronal sections were cut with a cryostat (Leica CM3050;
Leica Biosystems Nussloch GmbH, Nussloch, Germany).
Sections were washed several times in PBS followed by antigen
retrieval in 0.01 M sodium-citrate (pH = 6) at 80◦C for 30 min,
then permeabilized with 0.5% Triton-X100 for 20 min and
blocked in 2% normal goat serum in PBS for 1 h at room
temperature. The specificity of the primary antisera used in
this experiment was validated earlier (Theodorakis et al., 2006;
Gautron et al., 2011; Hrabovszky et al., 2011). Polyclonal
antibodies raised in guinea pig against GnRH (EH#1018; 1:5000;
48 h at 4◦C) were reacted with FITC conjugated anti-guinea pig
IgG (1:500; Jackson ImmunoResearch Laboratories). The rabbit
polyclonal GLP-1 antiserum (#T-4057; 1:2000; Peninsula Labs,
San Carlos CA, USA) was applied to the sections for 48 h at 4◦C,
then reacted with biotinylated anti rabbit-IgG (Jackson; 1:500 in
PBS for 2 h at room temperature), followed by Streptavidin-Cy3
(Jackson; 1:1000). Sections were mounted on glass slides, air-
dried and coverslipped in Mowiol (Calbiochem, San Diego, CA,
USA). Images were acquired by a Nikon C2 confocal microscope
(Nikon Corp., Tokyo, Japan).
Double-Labeling Immuno-Electron
Microscopy for nNOS and GnRH
Wild type and nNOS−/− mice were anesthetized with a mixture
of ketamine and xylazine (ketamine 50 mg/kg, xylazine 10 mg/kg
body weight, ip) and were perfused transcardially with 10 ml
0.01 M PBS pH 7.4, followed sequentially by 10 ml of 4%
paraformaldehyde in Na-acetate buffer, pH 6.0, and then by
50 ml of 4% paraformaldehyde in Borax buffer, pH 8.5. The
brains were rapidly removed and stored in 4% paraformaldehyde
in 0.1 M phosphate buffer (PB), pH 7.4, overnight at 4◦C.
Serial 25 µm thick coronal sections were cut on a Leica
VT 1000S vibratome through the preoptic area. The cortical
regions were removed from the sections of wild type animals
to be able to distinguish among the sections of wild type and
nNOS−/− animals. Then the wild type and nNOS−/− sections
were processed together.
The sections were treated with 0.5% H2O2 in PBS for 15 min,
cryoprotected in 15% sucrose in PBS for 15 min at room
temperature and in 30% sucrose in PBS overnight at 4◦C,
and then quickly frozen over liquid nitrogen and thawed. The
freezing-thawing cycle was repeated three times to improve the
antibody penetration.
The pretreated sections were incubated with 10% normal
horse serum for 20 min, and then were placed in a mixture
of rabbit anti-nNOS serum (1:200; #617000; Thermo Fisher)
and guinea pig anti-GnRH serum (1:30,000) for 4 days at 4◦C.
After rinsing in PBS and 0.1% cold water fish gelatin/1% bovine
serum albumin (BSA) in PBS, the sections were incubated in
donkey anti-rabbit IgG conjugated with 0.8 nm colloidal gold
(Electron Microscopy Sciences, Fort Washington, PA, USA)
diluted at 1:100 and biotinylated donkey anti-guinea pig IgG
diluted at 1:500 in PBS containing 0.1% cold water fish gelatin
and 1% BSA overnight at 4◦C. After washing in PBS, the sections
were fixed in 1.25% glutaraldehyde in 0.1 M PB for 10 min
at room temperature. After further rinsing in PBS the sections
were washed in Aurion ECS buffer (Aurion; 1:10) diluted in
distillated water (DW). The sections were rinsed in 0.2 M
sodium citrate pH 7.5, and then the gold particles were silver
intensified with the Aurion R-Gent SE-LM Kit. The sections
were placed in 0.05% gold-chloride for 2 × 5 min at room
temperature, washed in 0.2 M sodium citrate, pH 7.5, and in 3%
sodium-tiosulfate solution for 10 min each at room temperature.
Then the sections were treated in avidin-biotin-peroxidase
complex (ABC Elite 1:100) and the GnRH-immunoreactivity
(IR) was developed in 0.05% DAB/0.005% H2O2 in 0.05 M Tris
buffer, pH 7.6.
Sections were osmicated for 30 min at room temperature,
and then treated with 2% uranyl acetate in 70% ethanol for
30 min. Following dehydration in an ascending series of ethanol
and acetonitrile (Sigma), the sections were flat embedded in
Durcupan ACM epoxy resin (Fluka) on liquid release agent
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(Electron Microscopy Sciences)-coated slides, and polymerized
at 56◦C for 2 days. After polymerization, 60–70 nm thick
ultrathin sections were cut with Leica UCT ultramicrotome
(Leica Microsystems). The ultrathin sections were mounted onto
Formvar-coated, single slot grids, and examined with a JEOL-100
C transmission electron microscope.
The specificity of the antisera were described earlier: rabbit
antiserum against nNOS (Szabadits et al., 2007) and guinea pig
antiserum against GnRH (Hrabovszky et al., 2011).
Real-Time PCR Detection of Glp1r and
Nos1 in GnRH Neurons
Harvesting single-cell mRNAs using patch pipettes is a well-
established way to collect mRNA for RT-PCR from neurons,
including GnRH neurons in various laboratories (Pape et al.,
2001; Xu et al., 2008; Zhang et al., 2009, 2015; Tanaka
et al., 2010; Bhattarai et al., 2011). In our present study,
the mRNA content of the individual GnRH neurons of male
mice used in PCR experiments was also harvested using
the patch clamp pipette, as described earlier (Farkas et al.,
2013; Vastagh et al., 2015) with slight modification. Patch
pipettes were pulled from capillaries sterilized at 180◦C for
6 h and filled with autoclaved intracellular pipette solution
containing (in mM) HEPES 10, K-gluconate 130, KCl 10,
NaCl 10, EGTA 1 and MgCl2 0.1 (pH 7.3 with KOH,
osmolarity adjusted to 300 mOsm with D-sorbitol). The
resistance of the patch electrodes was 2–3 MΩ. The RNA
samples were collected from GnRH-GFP neurons of acute
brain slices kept in oxygenated aCSF at 33◦C (Farkas et al.,
2013; Vastagh et al., 2015) using extra care to avoid any
glial RNA contamination with the protocol suggested by Fuzik
et al. (2016). The collected cytoplasm was reverse transcribed
directly in 20 µl reactions using the ViLO SuperScript III
cDNA reverse transcription (RT) kit (Thermo Fisher Scientific,
Waltham, MA, USA). For negative controls, the intracellular
pipette solution was used in the RT reactions. The obtained
cDNA served as template for the subsequent pre-amplification
using the Preamp Master Mix kit (Thermo Fisher Scientific)
according to the manufacturer’s protocol. The pre-amplification
products were diluted 1:10 with 0.1× TE buffer before use in
qPCR. Real-time PCR was applied using inventoried TaqMan
gene expression assays (Thermo Fisher Scientific) as follows:
Gnrh1 (assay ID: Mm01315604_m1), Glp1r (Mm00445292_m1),
Nos1 (Mm01208059_m1), Gfap (Mm01253033_m1) and a
housekeeping gene Gapdh (Mm99999915_g1). Each assay
consisted of a FAM dye-labeled TaqMan MGB probe and two
primers. Thermal cycling conditions of the qPCR were as follows:
2 min at 50◦C and 20 s at 95◦C, followed by 40 cycles of 3 s at
95◦C and 30 s at 60◦C using the ViiA 7 real-time PCR platform
(Thermo Fisher Scientific). Each cDNA sample was checked for
Gfap mRNA expression and only Gfap-negative samples were
used in the analysis.
Due to the low expression of Glp1r, three pooled samples from
three mice were used in the RT-PCR experiments. Each pooled
sample contained 10 GnRH neurons. In order to investigate Nos1
expression, individual GnRH neurons were separately examined
(30 neurons from five animals).
Statistical Analysis
Each experimental group included minimum 10 neurons from
six to seven animals in the electrophysiological measurements.
Recordings were stored and analyzed off-line. Event detection
was performed using the Clampfit module of the PClamp 10.4
software (Molecular Devices).
Mean firing rate and mPSC frequency were calculated as
number of spikes divided by the length of the respective period
(5 min and 10 min, respectively). Bursts were defined according
to Lee et al. (2012). Burst frequency was calculated by dividing the
number of bursts with the length of the respective time period.
Intraburst frequency was calculated by dividing the number of
spikes with the length of the respective burst. Percentage changes
resulted from Exendin-4 application were calculated by dividing
the value to be analyzed before (5 min) and after (the subsequent
10 min) Exendin-4 administration.
Group data were expressed as mean ± standard error (SEM).
Statistical significance was analyzed using the ANOVA followed
by Newman-Keuls (NK) post hoc test (GraphPad Software Inc.,
La Jolla, CA, USA), and considered at p < 0.05 (i.e., 95%
confidence interval).
RESULTS
Exendin-4 Increases Firing Rate of GnRH
Neurons
Loose patch recordings revealed that silent (spontaneously not
firing) GnRH neurons (approx. 25% of all GnRH neurons) could
not be activated by Ex-4 administration and therefore, they were
discarded from the subsequent analysis. All of the firing GnRH
neurons recorded were burst-type neurons and in these neurons
Exendin-4 (1 µM; Eng et al., 1992; Raufman et al., 1992; Acuna-
Goycolea and van den Pol, 2004) increased the mean firing
rate to 434 ± 69.9% of the control (N = 10; ANOVA + NK;
p < 0.05; Figure 1A, Table 1). Frequency distribution graph
shows the time course of firing rate. Note that the effect of
Exendin-4 is washed out in 10 min (Figure 1A). The average
number of spikes within a burst increased to 162 ± 32.9%
(from 3.2 ± 0.2 to 5.2 ± 0.2, ANOVA + NK; p < 0.05), burst
frequency increased to 381 ± 65.2% (from 0.07 ± 0.03 Hz
to 0.26 ± 0.02 Hz, ANOVA + NK; p < 0.05), and intraburst
frequency increased to 172 ± 54.7% (from 6.2 ± 0.7 Hz to
10.7 ± 0.5 Hz; ANOVA + NK; p < 0.05) of the control. Lower
concentrations of Exendin-4 (100–500 nM) caused no significant
change in the average firing rate (Figure 1C, Table 1). In contrast,
a higher dose (5 µM) evoked a robust increase in the firing
rate (Figure 1C, Table 1). Dose-response curve (Figure 1C)
reveals that Exendin-4 is ineffective at 100–500 nM, but causes
profound increase in the firing rate at 1–5 µM. Therefore, the
1 µM concentration was used in all subsequent experiments.
Of note, this concentration is in a good accordance with the
dose used by other laboratories on other types of hypothalamic
neurons (Acuna-Goycolea and van den Pol, 2004). When the
brain slice was pretreated with the GLP-1R antagonist Exendin-
3(9–39) (1µM), no alteration in the basal firing rate was observed
(Table 2). Then, this pretreatment fully eliminated the effect of
Frontiers in Cellular Neuroscience | www.frontiersin.org 5 September 2016 | Volume 10 | Article 214
Farkas et al. GLP-1 Activates GnRH Neuron EC/NO-Dependently
FIGURE 1 | Effect of glucagon-like peptide-1 (GLP-1) agonist Exendin-4
on the firing of gonadotropin-releasing hormone (GnRH) neurons in
brain slices of male mice. (A) 1 µM Exendin-4 increases the firing rate in
GnRH neurons in 5 min. The frequency distribution graph under the recording
also shows this profound change. (B) Pretreatment of the brain slice with the
GLP-1 receptor (GLP-1R) antagonist Exendin-3(9–39) (1 µM) inhibits the effect
of Exendin-4 on firing. The frequency distribution graph under the recording
confirms this observation. (C) Bar graph shows the significant change in the
firing rate at 1 and 5 µM, but not at 100 and 500 nM. The graph also
demonstrates elimination of the effect upon pretreatment the brain slice with
the GLP-1R antagonist. Arrows show application of Exendin-4. ∗p < 0.05.
TABLE 1 | Changes in firing rate in gonadotropin-releasing hormone
(GnRH) neurons upon Exendin-4 administration at various concentrations
of this agonist.
Basal firing rate (Hz) After agonist Ex-4
in Hz in %
Ex-4 (100 nM) 0.57 ± 0.19 0.68 ± 0.22 121 ± 52.6
Ex-4 (500 nM) 0.50 ± 0.27 0.59 ± 0.23 118 ± 45.3
Ex-4 (1 µM) 0.52 ± 0.23 2.25 ± 0.18 434 ± 69.9∗
Ex-4 (5 µM) 0.61 ± 0.31 3.91 ± 0.22 642 ± 57.1∗
The first column contains firing rate before any drug administration (basal firing
rate), the second and third columns provide change in Hz and percentage in firing
rate after the single bolus agonist administration. ∗p < 0.05.
Exendin-4, the mean firing rate showed no change (98 ± 38.1%;
N = 10; Figure 1B, Table 2). Burst parameters showed no change
either. Bar graph summarizes the percentage changes in the mean
firing rate as a result of Exendin-4 application (Figure 1C),
demonstrating that Exendin-4 significantly increased mean firing
rate and the effect could be abolished by pretreatment with the
specific GLP-1R antagonist.
Effect of Exendin-4 on the GABAergic
mPSCs of GnRH Neurons
Positive correlation between the firing rate and the frequency of
GABAergic mPSCs in GnRH neurons has been well established
(Chu and Moenter, 2005; Christian and Moenter, 2007; Farkas
et al., 2010, 2013). Since Exendin-4 increased firing rate, we
investigated further the effect of Exendin-4 by examining its
action on the mPSCs. The administration of Exendin-4 (1 µM)
resulted in a significant increase in the mean mPSC frequency
(Figure 2A, Table 3) in all GnRH neurons studied, reaching
240.7 ± 30.42% of control values (N = 10; ANOVA +
NK; p < 0.05). The magnified periods and the distribution
graph of the frequency depicted under the recording also
demonstrated an elevated mPSC frequency, resulting from
Exendin-4 administration. Distribution graph revealed that the
frequency can reach a peak value as high as 20 Hz in individual
GnRH neurons following Exendin-4 application. Elevation of
the frequency started to disappear after 10 min washout period.
Amplitude of the mPSCs, however, showed no significant
alteration (107.5 ± 14.2%; Table 5). Rise and decay time
constants of the individual mPSCs showed no modification,
either (rise: 97.7 ± 21.9%, from 6.18 ± 1.27 to 5.99 ± 1.39 ms;
TABLE 2 | Changes in firing rate in GnRH neurons upon Exendin-4
administration with antagonist (Exendin3(9–39)) pretreatment.
Basal firing During antagonist After agonist Ex-4
rate (Hz) Ex3(9–39) (Hz) in Hz in %
Ex3(9–39) 0.56 ± 0.22 0.58 ± 0.32 0.57 ± 0.29 98 ± 38.1
The first column contains firing rate before any drug administration (basal firing
rate), the second column shows firing rate during antagonist pretreatment, the
third and fourth columns provide Hz and percentage change in firing rate after the
single bolus agonist administration.
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FIGURE 2 | Effect of Exendin-4 (1 µM) on the miniature postsynaptic currents (mPSCs) in GnRH neurons of male mice. (A) Exendin-4 increased the
frequency of the mPSCs with no change in the average amplitude. One-minute-long periods of the recording before and after application of Exendin-4 are drawn
under the recording. The time course of frequency depicted under the zoomed periods shows change in the frequency. (B) Effect of Exendin-4 on the mPSCs was
abolished by the pretreatment with Exendin-3(9–39). The zoomed periods and the frequency distribution graph confirm this observation. (C) Effect of Exendin-4 was
eliminated only partially when the slice was pretreated with the nitric oxide-synthase (NOS) inhibitor Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME).
(D) Similar partial inhibition was observed in the case of pretreatment with cannabinoid receptor type-1 (CB1) antagonist 1-(2, 4-dichlorophenyl)-5-(4-
iodophenyl)-4-methyl-N-(1-piperidyl)pyrazole-3-carboxamide (AM251). (E) Full blockade could be accomplished by simultaneous blocking of the NO- and
endocannabinoid signaling mechanisms. (F) Bar graph reveals that Exendin-4 significantly elevated the frequency of mPSCs. Full inhibition could be achieved by
antagonizing the GLP-1R, whereas blockade of either the NO or the endocannabinoid system results in partial inhibition only. Arrows show the onset of Exendin-4
administration. ∗p < 0.05.
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TABLE 3 | Changes in miniature postsynaptic currents (mPSC) frequency
upon application of Exendin-4 or L-arginine.
Basal frequency (Hz) Change after Ex-4 or L-arginine
in Hz in %
Ex-4 2.42 ± 0.26 5.81 ± 0.28 240.7 ± 30.42∗
L-arginine 2.26 ± 0.29 3.71 ± 0.31 164 ± 15.1∗
The first column contains mPSC frequency before any drug administration (basal
frequency), the second and third columns show frequency in Hz and % after single
bolus Exendin-4 or L-arginine administration. ∗p < 0.05.
decay: 92.9± 18.1%, from 26± 2.4 to 24± 3.2 ms). Pretreatment
of the brain slice with the antagonist Exendin-3(9–39) caused no
change in the basal mPSC frequency, but abolished the Exendin-4
evoked increase in this parameter (Figure 2B, Tables 4, 6)
providing evidence for the involvement of the GLP-1R in the
effect (102.4 ± 13.6%; N = 11, ANOVA + NK; p > 0.05). This
observation was confirmed by the zoomed periods under the
recording and the frequency distribution graph, respectively.
Involvement of NO and
2-Arachidonoylglycerol (2-AG) Signaling
Mechanisms
Increase in the frequency of the GABAergic mPSCs could be
evoked by activation of the NO machinery in hypothalamic
neurons (Di et al., 2009). Therefore, we examined whether
this mechanism was involved in the elevation of mPSC
frequency after Exendin-4 application in GnRH neurons. In
order to block NOS, the slices were pretreated with L-NAME
(100 µM). This pretreatment caused no alteration in the
basal mPSC frequency and amplitude (Tables 4, 6). Recording
of the mPSCs showed, however, that in the presence of
L-NAME Exendin-4 was still able to increase the frequency
of mPSCs to 144.5 ± 16.06% of the value measured prior
to Exendin-4 application without affecting the amplitude
(Figure 2C, Tables 4, 6). This percentage value was, however,
significantly lower (N = 12, ANOVA + NK; p < 0.05) than
the one observed in the absence of L-NAME. Nevertheless,
TABLE 5 | Changes in mPSC amplitude on GnRH neurons upon
application of Exendin-4 or L-arginine.
Basal amplitude (pA) Change after Ex-4 or L-arginine
in pA in %
Ex-4 38 ± 5.3 40 ± 5.6 107.5 ± 14.2
L-arginine 45 ± 4.7 43 ± 4.9 96 ± 10.6
full elimination of the Exendin-4 effect could not be achieved.
Both the zoomed periods and the frequency distribution graph
under the recording also revealed this partial attenuation.
The percentage elevation differed not only from the change
observed in the absence of L-NAME, but also from the value
when Exendin-4 was administered in the presence of GLP-1R
antagonist (p=<0.05).
Our earlier works suggested that tonic 2-AG release could
influence synaptic transmission to GnRH neurons (Farkas et al.,
2010). In order to examine whether modulation of this tonic
endocannabinoid release was also involved in the effect of
Exendin-4, the CB1 inverse agonist AM251 (1 µM) was applied
to the slice. In accordance with our earlier results, (Farkas et al.,
2010), blockade of the retrograde endocannabinoid signaling
machinery elevated the basal mPSC frequency without affecting
the amplitude (Tables 4, 6). Nevertheless, it decreased the effect
of Exendin-4 (Figure 2D, Tables 4, 6). The frequency of mPSCs
was raised by Exendin-4 to 153.1± 17.14% of the value recorded
before Exendin-4 application (Tables 4, 6). This percentage
increase is significantly lower (N = 11: ANOVA + NK; p< 0.05)
than the one measured in the absence of AM251. However,
similarly to the inhibition of the NO-release, administration of
AM251 did not fully eliminate the action of Exendin-4. Both the
magnified periods and the frequency distribution revealed that
elevation of the frequency of mPSCs also differed significantly
from the one measured in the presence of GLP-1R antagonist
(p< 0.05).
Blocking either NO-production or the presynaptic CB1
inhibited the effects of Exendin-4 only partially. Therefore,
we examined whether simultaneous blockade of both signaling
TABLE 4 | Changes in mPSC frequency upon application of Exendin-4 in the presence of various blockers.
Basal frequency (Hz) During antagonists Change after Ex-4
and inhibitors (Hz)
in Hz in %
Ex3(9–39) 2.22 ± 0.28 2.31 ± 0.37 2.35 ± 0.14 102.4 ± 13.6
L-NAME 2.50 ± 0.26 2.34 ± 0.49 3.37 ± 0.34 144.5 ± 16.06∗
AM251 2.28 ± 0.23 3.19 ± 0.37 4.88 ± 0.32 153.1 ± 17.14∗
L-NAME + AM251 2.26 ± 0.24 3.17 ± 0.32 3.23 ± 0.28 102.2 ± 12.8
GDP-βS 2.34 ± 0.23 2.30 ± 0.44 2.48 ± 0.18 108.0 ± 12.0
CPTIO 2.31 ± 0.26 2.44 ± 0.36 3.73 ± 0.32 153.3 ± 20.06∗
intraNPLA + AM251 2.25 ± 0.22 3.20 ± 0.29 3.35 ± 0.27 104.8 ± 6.15
L-NAME + AMG9810 2.42 ± 0.27 2.32 ± 0.29 2.46 ± 0.32 106.0 ± 9.87
NPLA + PF3845 2.18 ± 0.22 3.10 ± 0.32 3.13 ± 0.29 101.0 ± 4.36
The first column contains mPSC frequency before any drug administration (basal frequency), the second column shows frequency after various inhibitor pretreatments,
the third and fourth columns provide frequency change in Hz and percentage after single bolus Exendin-4 administration. ∗p < 0.05.
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TABLE 6 | Changes in mPSC amplitude on GnRH neurons upon application of Exendin-4 after pretreatment with various antagonists or inhibitors.
Basal During antagonists Change after Ex-4
amplitude (pA) and inhibitors (pA) in pA in %
Ex3(9–39) 41 ± 6.2 39 ± 4.8 37 ± 5.2 96 ± 11.5
L-NAME 35 ± 7.6 37 ± 6.3 37 ± 5.3 102 ± 12.2
AM251 32 ± 8.8 37 ± 6.4 37 ± 4.8 100 ± 11.6
L-NAME + AM251 39 ± 6.7 35 ± 7.2 35 ± 5.0 99 ± 8.7
GDP- βS 35 ± 6.1 36 ± 4.9 33 ± 5.7 93 ± 9.3
CPTIO 42 ± 5.5 38 ± 5.9 41 ± 6.1 110 ± 15.4
intraNPLA + AM251 43 ± 7.0 39 ± 5.7 41 ± 4.9 106 ± 12.3
L-NAME + AMG9810 43 ± 7.0 39 ± 5.7 41 ± 6.3 106 ± 12.3
NPLA + PF3845 40 ± 5.9 42 ± 4.5 40 ± 7.1 95 ± 8.9
mechanisms could eliminate the Exendin-4 triggered changes
in the mPSC frequency. The presence of both AM251 and
L-NAME in the aCSF fully abolished the effect of Exendin-4
(102.2 ± 12.8%; N = 10; Figure 2E, Tables 4, 6). The zoomed
recordings and the frequency distribution also confirmed this
result. Thus, activation of the GLP-1R resulted in no significant
modification in the frequency of the mPSCs, suggesting
simultaneous participation of both NO and endocannabinoid
retrograde signaling mechanisms.
Bar graph summarizes the effect of Exendin-4 on the mean
frequency of the mPSCs and full inhibition of the Exendin-4
triggered action by antagonizing GLP-1R. The graph also
depicts that blocking NO-synthesis and CB1 resulted in partial
elimination of the action of Exendin-4, whereas blockade of both
mechanisms abolished the Exendin-4 effect (Figure 2F).
Effect of Exendin-4 on GABAergic mPSCs
is Direct on GnRH Neurons via Activation
of NO-Production in the Recorded Neurons
GLP-1R is a member of the G-protein coupled receptor (GPCR)
family, and an intracellularly applied G-protein blocker GDP-β-S
is supposed to inhibit its function in the recorded GnRH neuron
exclusively, without affecting cells in the vicinity of the GnRH
neuron. In order to prove the direct action of Exendin-4 in
GnRH neurons, its effect on the mPSCs was further examined in
the intracellular presence of the GDP-β-S (2 mM). Intracellular
application of GDP-β-S caused no change in the basal mPSC
frequency and amplitude (Tables 2, 3), but eliminated the effect
of the GLP-1R agonist Exendin-4 on the frequency of the mPSCs
(108.0 ± 12.0%; N = 10; Figure 3A, Tables 4, 6). Both the
zoomed periods and the frequency distribution graph support
this result.
Earlier in this manuscript we showed the involvement of NO-
signaling in the action of Exendin-4. To determine the cellular
source of NO, we dissected this regulatory mechanism further
by applying the NO-scavenger CPTIO (1 mM) intracellularly in
the GnRH neuron. The pretreatment alone exerted no effect on
the basal mPSC frequency and amplitude (Tables 4, 6). Under
such circumstances, administration of Exendin-4 increased the
frequency of the mPSCs to 153.3± 20.06% of the value measured
before agonist application (N = 12; ANOVA + NK; p < 0.05),
although it was still significantly lower than in the absence of
CPTIO (p < 0.05; Figure 3B, Tables 4, 6). Magnified periods
and the frequency distribution under the recording verified this
partial inhibition.
In another experiment the nNOS inhibitor NPLA was applied
intracellularly (1 µM) in the extracellular presence of AM251
(1 µM) and then the effect of Exendin-4 was examined on
the mPSCs of GnRH neurons. As expected, the pretreatment
alone elevated frequency of the mPSCs due to the inhibition
of the tonic 2-AG release without affecting the amplitude.
Simultaneous application of NPLA and AM251 fully abolished
action of Exendin-4 on the frequency of mPSCs (104.8 ± 6.15%
of the value before Exendin-4 was added, Figure 3C, Tables 4, 6),
verifying further that GnRH neuron was the source of the
released NO. The zoomed periods together with the frequency
distribution graph also demonstrates the total inhibition.
The Retrograde 2-AG Pathway is
Regulated by Anandamide-TRPV1
Signaling
A recent article has revealed the involvement of the TRPV1
receptor in the inhibition of 2-AG production and in
the retrograde endocannabinoid signaling mechanism in
hippocampal neurons (Lee et al., 2015). We also examined
the putative role of TRPV1 in the decreased tonic 2-AG
production in GnRH neurons. Intracellular administration of
the TRPV1 antagonist AMG9810 (10 µM) in the presence of
L-NAME showed no alteration in the basal mPSC frequency and
amplitude, but it completely abolished the effect of Exendin-4
on the frequency of mPSCs in GnRH neurons (106.0 ± 9.87%;
N = 12; Figure 3D, Tables 4, 6).
Anandamide is an endogenous ligand of TRPV1. Thus,
we investigated its role in the activation of TRPV1 by
inhibiting FAAH (degrading enzyme of anandamide). The
FAAH inhibitor PF3845 (5 µM) was applied intracellularly
whereas the NO signaling was blocked by the nNOS inhibitor
NPLA (1 µM). Under these conditions, the basal mPSC
frequency and amplitude showed no change (Tables 4, 6), but
the action of Exendin-4 on the mPSC frequency was fully
eliminated in GnRH neurons (101.0± 4.36%; N = 10; Figure 3E,
Tables 4, 6).
In order to confirm further the function of NO in GnRH
neurons, the NO-donor L-arginine (1 mM) was applied in
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FIGURE 3 | Exendin-4 acts directly on GnRH neurons by activating a retrograde NO- and an anandamide-transient receptor potential vanilloid 1
(TRPV1) signaling mechanism. (A) Exendin-4 was unable to modify frequency of mPSCs when G-proteins were intracellularly blocked by GDP-β-S in the recorded
GnRH neuron. (B) Partial inhibition was observed when the NO-scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (CPTIO) was applied
intracellularly in the GnRH neuron. (C) Full inhibition was achieved when neuronal NO synthase (nNOS) was inhibited by the intracellularly applied
N5-[Imino(propylamino)methyl]-L-ornithine hydrochloride (NPLA) and the endocannabinoid pathway was blocked by AM251. (D) Simultaneous blocking of NOS by
L-NAME and intracellular inhibition of the TRPV1 receptor by 2E-N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl)phenyl]-2-Propenamide (AMG9810) in
the GnRH neuron abolished the effect of Exendin-4. (E) Inhibition of both nNOS by NPLA and anandamide degradation by PF3845 resulted in full elimination of
action of Exendin-4. (F) The NO-donor L-arginine elevated frequency of the mPSCs. Arrows show the onset of Exendin-4 or L-arginine administration.
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FIGURE 4 | Summary graph of data demonstrating direct action of Exendin-4 and resting potential measurement. (A) Bar graph reveals that elevation of
the frequency of mPSCs resulted from direct activation of GLP-1R in GnRH neurons. This action activates a NO-signaling machinery and involves an
anandamide-TRPV1-coupled mechanism. The Exendin-4 data were taken from Figure 2 for an easier comparability. (B) Exendin-4 does not affect resting
membrane potential (Vrest) in GnRH neurons. Arrow shows onset of the Exendin-4 application. ∗p < 0.05.
the aCSF. Application of L-arginine resulted in elevation of
frequency of mPSCs (164 ± 15.1%; p < 0.05) with no change in
the amplitude (96± 10.6%; N = 10; Figure 3F, Tables 3, 5).
Bar graph summarizes these results. Partial inhibition of
the action of Exendin-4 was observed when NO-production
was eliminated by intracellularly scavenging the produced
NO molecules. In contrast, full inhibition was achieved when
G-proteins were blocked in the recorded GnRH neurons.
Simultaneous inhibition of the nNOS and anandamide-
TRPV1 pathways also completely abolished the effect
(Figure 4A).
In an additional experiment, effect of Exendin-4 on the resting
membrane potential (Vrest) was examined (Figure 4B). The
measurements showed no significant change in this parameter
demonstrating that ion channels contributing to the level of Vrest
are not involved in the process.
GnRH Neurons are Contacted by GLP-1
Immunoreactive Axons in Mice
In accordance with previous data (Larsen et al., 1997; Sarkar
et al., 2003; Llewellyn-Smith et al., 2011), we have now
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FIGURE 5 | Interaction of central GLP-1 and GnRH neuronal systems.
(A) Red GLP-1-immunoreactive (IR) axons (arrowheads) and a green GnRH-IR
neuron (arrows) appear in the vicinity of the vascular organ of lamina terminalis
(OVLT) of the mouse brain. (B,C) GLP-1-IR axons establish contacts with the
dendrites (enframed by dotted line) of a subset of GnRH neurons exhibiting
smooth (B) or rough (C) surface. The multiple contacts (arrowheads) are
shown at higher power in insets (B1,C1).
detected dense network of GLP-1 IR fibers of the hypothalamic
dorsomedial and paraventricular nuclei, the periventricular
region of the third ventricle (not shown), the region of the
vascular OVLT and the preoptic area where the majority
of GnRH neurons reside. The putative involvement of the
brain-born GLP-1 in the central regulation of reproduction
was studied by the simultaneous detection of the GnRH
and GLP-1-IR neuronal systems. Individual GnRH-synthesizing
neurons scattered within the network of GLP-1-IR axons
(Figure 5A). GLP-1-IR axons approached and established
single or occasionally, multiple contacts with one tenth of
GnRH neurons. Distribution of the contacts was rather
inhomogeneous and exhibited the highest density in the
proximity of the OVLT. GLP-1 inputs often targeted the
dendritic compartment of GnRH cells (Figures 5B,C). Both
the smooth surfaced (Figure 5B) and the rough surfaced
(Figure 5C) subtypes of GnRH neurons (Liposits et al., 1984;
Witkin and Demasio, 1990) received GLP-1-IR axons. The
insets (B1,C1) in Figures 5B,C demonstrate at high power an
example for the multiple axo-dendritic contacts established by
GLP-1-IR axons on the interacting GnRH neurons in confocal
images.
Double-Labeling Immuno-Electron
Microscopy Demonstrates Presence of
nNOS in GnRH Neurons
To demonstrate the presence of nNOS in the GnRH
neurons, double-labeling immuno-electron microscopy
was performed. A large number of highly electron dense
gold-silver particles denoting the nNOS-IR was detected in
the GnRH neurons that were recognized on the presence
of the electron dense DAB chromogen. nNOS-IR was
present in both the perikaryon (Figures 6A–C) and dendrite
(Figure 6D) of GnRH neurons. nNOS-IR was also observed
in numerous non-GnRH neurons of the preoptic area,
including those residing in the close vicinity of the nNOS-
positive GnRH neurons (Figure 6C). In contrast to wild-
type animals, in transgenic nNOS−/− mice the immuno-
electronmicroscopic study could not detect any specific sign for
the expression of nNOS in GnRH and non-GnRH neurons (not
shown).
RT-PCR Confirms the Expression of Glp1r
and Nos1 Genes in GnRH Neurons of Mice
In addition to Gnrh1 mRNA, expression of Glp1r mRNA
was detected in pooled, patch pipette-harvested GnRH-GFP
neuron cytoplasm samples at cycle threshold (Ct) 32.7 ± 0.4.
The Ct value of Gapdh was 22.3 ± 0.1 (Figure 7A). None
of the transcripts were detected in the negative control
samples.
Expression of Gnrh1 mRNAs was also verified in each patch
pipette-harvested individual GnRH-GFP cytoplasm sample at Ct
value of 24.5 ± 0.8. We monitored the samples for potential
glial contamination by detecting Gfap mRNA. Samples with
any Gfap mRNA expression were omitted from the study.
Amplification curves showed that GnRH neurons expressed
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FIGURE 6 | Co-localization of nNOS and GnRH in the preoptic area of
mice. Electron micrographs showing strong nNOS immunogold labeling in
GnRH neurons (A–D). The nNOS-immunoreactivity (nNOS-IR) is detected with
highly electron dense gold–silver particles (arrows), while the presence of the
electron dense DAB chromogen identifies the GnRH-IR structures. nNOS-IR
characterizes both perikarya (A–C) and dendrites (A,D) of GnRH neurons.
Low-power micrograph (A) illustrates the overall presence of nNOS-IR in the
perikaryon and processes of a fusiform GnRH neuron. High-power
micrographs (B–D) depict the localization of nNOS-IR in the perinuclear
cytoplasm (B,C) and the dendritic domain (D) of immunolabeled GnRH
neurons. Note the expression of nNOS in a neuron located left to the
double-labeled GnRH cell (C). Scale bar = 1 µm in (A) and 0.4 µm in (B–D),
Nu, nucleus; GnRH, gonadotropin-releasing hormone neuron.
Nos1 mRNA (Ct 29.5 ± 1.5; Figure 7B). Presence of Nos1
transcript was detected in 5 out of 11 GnRH cytoplasmic samples.
The cycle threshold value of the housekeeping gene Gapdh was
23.3± 0.3.
DISCUSSION
Earlier studies described the modulatory effect of GLP-1 on
reproduction. In our present work we have provided compelling
evidences for the direct regulatory action of GLP-1 on GnRH
neurons. Accordingly: (1) GLP-1 excites firing and increases
frequency of GABAergic mPSCs in GnRH neurons via GLP-1R;
(2) downstream events of GLP-1R involve two retrograde
signaling pathways: activation of NO- and suppression of 2-AG
signaling mechanisms; (3) suppression of 2-AG pathway is
mediated via anandamide-TRPV1 signaling.
GLP-1 Is Excitatory to GnRH Neurons via
GLP-1R
Our results demonstrated that GLP-1 agonist exerts excitatory
effect in GnRH neurons. Both firing rate and frequency of
GABAergic mPSCs increased upon Exendin-4 administration.
Elevation in both firing rate and mPSC frequency correlates well
because GABA is excitatory via GABAA-R in GnRH neurons
(Sullivan et al., 2003; Farkas et al., 2010), although we have to note
that GABA is inhibitory via GABAB-R (Herbison and Moenter,
2011; Liu and Herbison, 2011). Our data are in accordance
with a recent investigation showing stimulatory effect of GLP-1
in neurons of the paraventricular nucleus, the bed nucleus of
the stria terminalis and the hippocampus (Cork et al., 2015).
Excitatory role of GLP-1 on the reproductive axis has already
been suggested, too (Beak et al., 1998; MacLusky et al., 2000;
Outeiriño-Iglesias et al., 2015). Our finding is also supported
by other studies showing increased spike and mPSC frequency
in hypothalamic hypocretin/orexin neurons (Acuna-Goycolea
and van den Pol, 2004) or revealing elevated c-fos level and
firing rate in neurons of parabrachial nucleus (Richard et al.,
2014). Furthermore, GLP-1 is able to modulate GABAA-R-
mediated synaptic currents in hippocampus (Korol et al., 2015)
providing further confirmation of our results. The Exendin-4
evoked activation of both firing and mPSCs in GnRH neurons
could be antagonized by GLP-1R antagonist suggesting a pivotal,
direct role of this receptor in the action. In addition, expression
of GLP-1R mRNA was found in the transcriptome of GnRH
neurons, indicating the presence of GLP-1R in these cells.
Intracellular blockade of GLP-1R, a member of the GPCR family,
by GDP-β-S and the subsequent abolishment of the Exendin-4
triggered change in the mPSC frequency also demonstrated
existence of functional and active GLP-1R in GnRH neurons.
The intracellularly applied NO-scavenger CPTIO, the TRPV1
inhibitor AMG9810 and the FAAH inhibitor PF3845 were
effective, too, confirming further the direct action of Exendin-4
in GnRH neurons. Thus, direct effect of GLP-1 agonist on GnRH
neurons is revealed beside its earlier suggested indirect action via
kisspeptin neurons (Outeiriño-Iglesias et al., 2015).
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FIGURE 7 | Expression of Glp1r and Nos1 mRNAs in GnRH neurons harvested by patch electrodes for single-cell qPCR. Real-time qPCR amplification of
Gnrh, Gapdh, Glp1r and Nos1 cDNA from GnRH neurons. (A) Expression of Glp1r transcript was detected in two of three pools of GnRH neuronal cytoplasmic
samples. The abundance of the Glp1r was low, indicated by its relatively high Ct values (32.5 and 33.1) as compared to the housekeeping gene Gapdh (22.0–22.5).
(B) Expression of the Nos1 gene in individually harvested Gfap-negative GnRH neuronal samples. The logarithmic scale of Rn and number of PCR cycles are
indicated on the Y and X axes, respectively. The onset of the exponential phase (Ct) is indicated by horizontal lines for each target gene. Column charts are in the
inserts to show quantitative results of the qPCR experiments.
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Although most of the researchers agree that the recorded
mPSCs in GnRH neurons are GABAergic under basal conditions,
theoretically we cannot exclude that the Exendin-4 induced
alteration in the mPSCs is due to the release of glutamate. In
our experiments, however, rise and decay time constant (tau)
parameters of the PSCs showed no change upon Exendin-4
administration. Since glutamatergic PSCs exhibit significantly
shorter tau values than GABAergic ones (Smith and Dudek,
1996), we found no indications for the effect of Exendin-4 on
glutamatergic neurotransmission.
One of the putative sources of GLP-1 reaching GnRH
neurons was also revealed. GLP-1-IR fibers contacted subset of
GnRH neurons in mouse samples showing the assumed role of
brain-born GLP-1. Various hypothalamic loci are innervated by
GLP-1-containing fibers (Renner et al., 2012; Katsurada et al.,
2014) originating from the NST. In this view, it is not surprising
that areas where GnRH neurons reside are also innervated
by GLP-1-IR axons. The results confirm our hypothesis that
GnRH neurons are able to sense metabolic status of the body
receiving input signals both directly from the periphery by the
gut-born GLP-1 level and indirectly via the brain-born GLP-1
from NST. The multiple sources of the sensed GLP-1 (gut-
born via the blood-brain barrier vs. brain-born) can also explain
the quasi-contradiction between the ratio of GLP-1 contacted
GnRH neurons (10%) and the high proportion of GnRH neurons
responding to GLP-1 in the electrophysiological experiments
(100%).
Effect of Exendin-4 on GnRH Neurons is
Mediated Partially by Activation of the NO
Retrograde Signaling
The electrophysiological results revealed the involvement of the
NO retrograde signaling mechanisms in the Exendin-4 evoked
action. Inhibition of NOS by L-NAME partially eliminated
the rise in the frequency of mPSCs, suggesting that this rise
was partially due to an elevated NO level. Scavenging NO
intracellularly by the membrane-impermeable CPTIO (Makara
et al., 2007) in GnRH neurons provided evidence that the
measured GnRH neuron itself was the source of NO in this effect.
Involvement of NO-signaling in action of GLP-1 has already
been reported at various sites in the brain (Chien et al., 2015;
Zhao et al., 2015). Furthermore, our work showing increased
mPSC frequency but not mPSC amplitude or rise/decay tau
indicates presynaptic excitatory function of the GnRH-produced
NO. This has led to the speculation that NO travels as retrograde
messenger from the post- to the presynaptic cell (Schuman and
Madison, 1991). Similar NO-related retrograde mechanism has
already been suggested in the hypothalamus, too (Borgquist et al.,
2015).
The actions of NO on reproduction are rather complex.
Sodium nitroprusside, a NO-donor, stimulated GnRH release
from hypothalamic explants (Moretto et al., 1993). The
immortalized, GnRH-producing GT1–7 neuronal cell line
expressed nNOS and an enhanced GnRH secretion was
observed in these cells when L-arginine, a precursor of
NO was administered (Mahachoklertwattana et al., 1994).
Leptin-dependent NO signaling in the preoptic region was
also shown to facilitate reproduction (Bellefontaine et al.,
2014). In contrast, other researchers found suppressive effect
of NO on LH secretion (Pinilla et al., 1999). In addition,
earlier studies reported absence of nNOS in GnRH neurons
(Grossman et al., 1994; Herbison et al., 1996) and that NO
inhibited spontaneous firing in adult GnRH neurons (Clasadonte
et al., 2008). Our present work revealed the expression of
nNOS mRNA and the presence of nNOS protein in mouse
GnRH neurons. The high resolution of the used immuno-
electron microscopic technique combined with the dual-pH
fixation of the samples resulted in the discovery of nNOS
protein in mouse GnRH neurons. It can also resolve the
discrepancy between our present ultrastructural results and
those earlier published light microscopic findings (Grossman
et al., 1994; Herbison et al., 1996; Ishihara et al., 2001;
Hanchate et al., 2012) that reported the absence of nNOS
protein in GnRH neurons. Our electrophysiological investigation
provided further proof for NO production of GnRH neurons,
which exerts stimulatory action on presynaptic GABAergic
axon terminals innervating GnRH neurons. In addition, the
NO-donor L-arginine triggered a rise in the mPSC frequency
providing further evidence for a functional NO-pathway in
GnRH neurons. These data are supported by an earlier article
(Varju et al., 2009) also demonstrating expression of nNOS
in the GnRH-producing GT1–7 neurons. The discrepancy
between our results and those of Clasadonte et al. (2008)
can be explained by the different experimental conditions
such as recording temperature (room temperature vs. 33◦C).
Since enzymatic processes (such as the ones involving DGL
and nNOS), ion pumps and exchanger fluxes are extremely
sensitive to the temperature, this might explain differences. In
addition, intracellular (pipette) solution contained low chloride
concentration (10 mM) in the work of Clasadonte et al.
(2008), whereas we used high-chloride (130 mM) pipette
solution in our measurements. Since the physiological chloride
content of GnRH neurons is high, the present approach
mimics more effectively the physiological condition of GnRH
neurons. Nevertheless, although our study reveals that NO
released from GnRH neuron as retrograde messenger triggered
excitation by acting presynaptically on GABAergic input, it
cannot be excluded that NO may elicit inhibition of GnRH
neurons when it is anterogradely released from neighboring,
non-GnRH neurons and act at postsynaptic sites of GnRH
neurons.
Exendin-4 Acts Partially via Retrograde
Endocannabinoid Signaling Pathway in
GnRH Neurons
Our study also showed involvement of the retrograde
endocannabinoid signaling in the Exendin-4 evoked action.
Blockade of CB1 by AM251 resulted in partial inhibition
of the Exendin-4 induced effect. In addition, intracellular
inhibition of GLP-1R by the G-protein inhibitor GDP-β-S
and the resulting total elimination of the effect of Exendin-4
demonstrated that GnRH neuron was the source of not
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only the NO but also the endocannabinoids mediating
the effects of Exendin-4. The presence of the tonic 2-AG
retrograde endocannabinoid machinery which can decrease
the activity of the GABAergic input to GnRH neurons has
already been reported (Farkas et al., 2010). Its role in the
mediation of the effect of metabolic signals was also described
in various neurons, including GnRH cells (Kola et al., 2008;
Farkas et al., 2013). The 2-AG retrograde signaling inhibits
GABAergic input to GnRH neurons (Farkas et al., 2010,
2013), however, Exendin-4 triggered excitation in these cells,
even when NO signaling was blocked by L-NAME or by the
intracellularly applied CPTIO. Therefore, we can deduce that
stimulation of GLP-1R results in suppression of the 2-AG
pathway. A recent article showed that 2-AG production can
be decreased in neurons by activating TRPV1 (Lee et al.,
2015). Furthermore, stimulation of GPCRs such as muscarinic
acetylcholine receptors or metabotropic glutamate 5 receptors
can activate TRPV1 by elevating anandamide level (Maccarrone
et al., 2008; Musella et al., 2010). TRPV1 regulates local
calcium level below the postsynaptic membrane (Cristino
et al., 2006) suppressing activity of DGL and 2-AG production
and eventually decreasing GABAergic neurotransmission
in striatal neurons (Maccarrone et al., 2008; Musella et al.,
2010). These results fit our findings that the GPCR GLP-1R
can reduce the tonic 2-AG inhibition of the GABAergic
neurotransmission to GnRH neurons through an anandamide-
TRPV1 signaling.
A logical question arises why anandamide, which can also
bind to CB1, induces no decrease in the mPSC frequency.
Theoretically, increased level of anandamide may indeed
mimic 2-AG effects and act on presynaptic CB1. However,
FAAH (degrading enzyme of anandamide) is postsynaptic,
FIGURE 8 | Schematic illustration of GLP-1R signaling in GnRH neurons and its proposed action on presynaptic GABA release. Effect of the GLP-1R
agonist (Exendin-4) or antagonist (Exendin-3) is mediated by G-protein complex, which may activate two retrograde signaling cascades. The first pathway involves
activation of the intracellular TRPV1 which decreases postsynaptic production and release of 2-AG resulting in the suppression of inhibition of the presynaptic GABA
release. The second one involves the release of NO produced by nNOS which increases the release probability and vesicular reuptake of GABA at the presynaptic
terminal. Abbreviations: GLP-1R, glucagon-like peptide 1 receptor; AC, adenylate cyclase; Gα, Gβ, Gγ, G-protein subunits; DAG, diacylglycerol; DGL, DAG-lipase;
CB1, cannabinoid receptor type-1; AM251, CB1 antagonist; 2-AG, 2-arachidonoylglycerol; GABAA-R, GABAA receptor; PKA, protein kinase A; nNOS, neuronal nitric
oxide synthase; L-NAME, Nω-Nitro-L-arginine methyl ester hydrochloride, a NOS inhibitor; NPLA, N5-[Imino(propylamino)methyl]-L-ornithine hydrochloride, a nNOS
inhibitor; GDP-β-S, GDP-Beta-S trilithium salt, a G-protein inhibitor; CPTIO, Carboxy-PTIO potassium salt, a NO scavenger; TRPV1, transient receptor potential
vanilloid 1; AEA, anandamide; AMG9810, TRPV1 antagonist; FAAH, fatty acid amide hydrolase; PF3845, FAAH-inhibitor. Red lines depict inhibitory actions, blue line
refers to excitatory action, and dotted lines represent hypothetical relations.
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whereas monoacylglycerol lipase (MGL; degrading enzyme
of 2-AG) is presynaptic (Gulyas et al., 2004), and brain
2-AG concentration is 170 times higher than anandamide
concentration (Stella et al., 1997). Conversely, DGL, the
synthesizing enzyme of 2-AG, also occurs postsynaptically in
the somato-dendritic domain of neurons, in which FAAH
is located (Gulyas et al., 2004; Katona et al., 2006). These
data, therefore, do not support the scenario that anandamide
could exert a significant direct effect on the presynaptic
CB1. Rather, this molecular architecture suggests that instead
of acting on the presynaptic CB1, postsynaptic elevation
of anandamide level may interfere with the postsynaptic
mobilization of 2-AG.
The NO and Endocannabinoid Retrograde
Signaling Pathways are Simultaneously
Involved in the Effect of Exendin-4
Blockade of either nNOS or CB1 resulted in partial inhibition
of the effect of Exendin-4. In contrast, simultaneous blockade
of both pathways hindered action of Exendin-4 completely.
The results suggest that activation of GLP-1R in GnRH neuron
initiates production of NO and suppression of tonic 2-AG
as proposed in Figure 8. The schematic diagram describes
the proposed mechanism of action of GLP-1 agonist where
binding of Exendin-4 to GLP-1R stimulates nNOS via a
G-protein mediated pathway. Activated nNOS then results in
higher level of NO, which diffuses out from GnRH neuron
to stimulate GABA release from the presynaptic terminal.
In parallel, binding of Exendin-4 represses synthesis and
release of tonic 2-AG via an anandamide-TRPV1-controlled
pathway. Suppression of 2-AG in GnRH neurons eventually
results in further facilitation of GABA release from the
presynaptic terminal into the synaptic cleft. Simultaneous
involvement of both NO and endocannabinoid retrograde
signaling mechanisms has already been described in the
hypothalamus (Di et al., 2009). In their report, Di et al.
(2009) found that glucocorticoid suppressed the glutamatergic
and facilitated the GABAA-R associated GABAergic input
to magnocellular neurons of the rat supraoptic nucleus
(SON). These glucocorticoid-induced effects were mediated
via GPCR and activated retrograde neuronal NO release and
endocannabinoid synthesis simultaneously. Nevertheless, the
glucocorticoid-related events in the SON are somewhat different
from the GLP-1 agonist-triggered ones we found in GnRH
neurons because glucocorticoid administration activated both
NO and endocannabinoid retrograde mechanisms whereas
stimulation of GLP-1R triggered NO release but suppressed
2-AG production. The reason behind this discrepancy might be
the distinctive excitatory role of GABAA-R in GnRH neurons.
Increase in the frequency of the GABAergic
neurotransmission could by itself indicate presence of a
presynaptic effect of GLP-1. However, various intracellular
blockades of the G-proteins and the cannabinoid and NO
pathways in the postsynaptic GnRH neurons inhibited action
of GLP-1, excluding this opportunity. Our results, therefore,
suggest the direct postsynaptic effect of GLP-1 and activation
of the two parallel retrograde signaling mechanisms in GnRH
neurons.
The role of GLP-1 in reproduction is rather controversial.
Although GLP-1R KO mice are fertile (Preitner et al., 2004),
male mice exhibit reduced gonadal weight and female mice
show delayed puberty (MacLusky et al., 2000). Human clinical
studies and case reports also indicate that GLP-1 plays important
roles in the regulation of human fertility (Jeibmann et al.,
2005; Fontoura et al., 2014). These observations suggest that
although lack of GLP-1 signaling may have no substantial
effects on reproduction, this peptide is capable to modulate
the reproductive axis. In our present work, we have provided
compelling evidence that GLP-1 agonist is able to act directly
on GnRH neurons, and this action is mediated by activation of
retrograde NO and anandamide-TRPV1-mediated suppression
of 2-AG endocannabinoid signaling mechanisms.
Although half-life of endogenous GLP-1 is less than 2 min in
the blood-stream (Kieffer et al., 1995) because of its cleavage by
dipeptidyl peptidase-4 (DPP-4), recent works have demonstrated
that various GLP-1 analogs widely used for treatment of type
2 diabetes and/or obesity are DPP-4 resistant due to their
modified molecular structure (Barrera et al., 2009; Katsurada
and Yada, 2016). Therefore, these analogs have longer half-
life such as several hours. In addition, they can cross the BBB
(Hunter and Hölscher, 2012) and remain in the brain for several
hours (Secher et al., 2014). In the hypothalamus, fluorescence
labeled analogs were observed in the median eminence and the
OVLT (Katsurada and Yada, 2016). Thus, our results suggest
that GLP-1 agonists might affect regulation of reproduction at
the level of GnRH neurons. Furthermore, activation of the NO
and anandamide-TRPV1-sensitive endocannabinoid pathways
can provide options to fine-tune the reproduction-specific effects
of GLP-1.
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